Liver transplantation (LT) is a life-saving operation but, with a limited donor pool, especially in Australia and New Zealand, patient selection for the waitlist remains crucial. The indication for LT should be assessed independent of the aetiology. Whilst there have been challenges in justifying LT for patients with acute alcoholic hepatitis (AH) and unresectable colorectal cancer liver metastases (CRLM) owing to previous reports of poor survival rates, the evidence landscape is changing. The aim of this manuscript is to review these specific, and evolving, indications for LT, namely AH and CRLM.
|Number of pages||6|
|Journal||Transplant Journal of Australasia|
|Publication status||Published - Apr 2022|